([email protected]), are senior scientists, both specializing in protein mass spectrometry for Thermo Fisher Scientific.
Blood-brain barrier permeability in ESKD a proof-of-concept study
July 2024: New Study Connects Ozempic to Blindness A rare type of partial blindness has emerged as a prominent concern for Ozempic patients following new findings that link semaglutide to sudden, often permanent vision loss in one eye
Individuals exploring BPC 157 peptide benefits for gut health and systemic inflammation support
Future directions First, define exposureresponse with quantitative pharmacokinetics and, where possible, receptor-occupancy or target-engagement biomarkers to guide dose selection across tissues
Of course, players like Noom and Hims & Hers have already lowered their BMI thresholds and use a microdosing strategy for these customers and its only a matter of time until we see this strategy writ large in the cash-pay channels